Millennium Management’s Bionano Genomics BNGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-167
Closed -$2.88K 5879
2024
Q4
$2.88K Sell
167
-1
-0.6% -$17 ﹤0.01% 5837
2024
Q3
$4.58K Sell
168
-9
-5% -$280 ﹤0.01% 5929
2024
Q2
$7.22K Buy
+177
New +$9.73K ﹤0.01% 5645
2024
Q1
Sell
-3,274
Closed -$371K 6195
2023
Q4
$371K Buy
3,274
+170
+5% +$17.8K ﹤0.01% 4832
2023
Q3
$564K Sell
3,104
-2,447
-44% -$641K ﹤0.01% 4586
2023
Q2
$2.03M Buy
+5,551
New +$2.51M ﹤0.01% 3468
2023
Q1
Sell
-1,949
Closed -$1.71M 6389
2022
Q4
$1.71M Buy
1,949
+1,897
+3,648% +$2.39M ﹤0.01% 3697
2022
Q3
$58K Buy
+52
New +$68.7K ﹤0.01% 6134
2022
Q2
Sell
-400
Closed -$620K 6987
2022
Q1
$620K Sell
400
-894
-69% -$1.21M ﹤0.01% 4947
2021
Q4
$2.32M Buy
1,294
+1,000
+340% +$2.67M ﹤0.01% 3638
2021
Q3
$971K Sell
294
-5,036
-94% -$17.6M ﹤0.01% 4723
2021
Q2
$23.4M Buy
5,330
+4,914
+1,181% +$19.4M 0.01% 1068
2021
Q1
$2.02M Buy
416
+394
+1,791% +$2.22M ﹤0.01% 3527
2020
Q4
$40K Buy
+22
New +$8.22K ﹤0.01% 5099
2019
Q4
Sell
-48
Closed -$20K 4213
2019
Q3
$20K Sell
48
-21
-30% -$22.9K ﹤0.01% 4088
2019
Q2
$102K Sell
69
-7
-9% -$14.3K ﹤0.01% 3890
2019
Q1
$199K Sell
76
-5
-6% -$13.1K ﹤0.01% 3736
2018
Q4
$254K Buy
+81
New +$323K ﹤0.01% 3297

Other funds holding BNGO

Millennium Management's BNGO Position: Q1 2025 in Review

Millennium Management sold out of Bionano Genomics (BNGO) in Q1 2025, closing a stake of 167 shares — an estimated $2.88K sold.

Millennium Management first reported a position in BNGO in Q4 2018 and held it in 18 quarters. The position peaked at $23.4M in Q2 2021. 30 funds tracked by Wall St. Rank hold BNGO as of Q1 2025.

  • Millennium Management reported no remaining Bionano Genomics position as of Q1 2025 after selling out during the quarter.
  • Millennium Management sold 167 Bionano Genomics shares in Q1 2025, an estimated $2.88K.
  • Millennium Management first reported a position in Bionano Genomics in Q4 2018 and held it in 18 quarters.
  • Millennium Management's Bionano Genomics position peaked at $23.4M in Q2 2021.
  • 30 funds tracked by Wall St. Rank held Bionano Genomics as of Q1 2025.

Based on Millennium Management's 13F filing for Q1 2025, filed 15 May 2025.